DAWES KAREN A (CIK 1261506) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-09). Recent activity: Sell BRNS (1,700 shares), Buy RGEN (995 shares), Sell RGEN (275 shares), Buy RGEN (973 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | Barinthus Biotherapeutics plc. (BRNS) | Director | Sell | 1,700 | $0 |
| 2026-05-18 | REPLIGEN CORP (RGEN) | Director | Buy | 995 | $0 |
| 2025-12-18 | REPLIGEN CORP (RGEN) | Director | Sell | 275 | $44,275 |
| 2025-05-19 | REPLIGEN CORP (RGEN) | Director | Buy | 973 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-09